GoodRx

Agile Therapeutics Announces New Agreement with vitaCare® Prescription Services to Improve Access to Twirla®

Retrieved on: 
Tuesday, June 13, 2023
Telehealth, Partnership, GoodRx, Retail, Woman, Channel, NHS Electronic Prescription Service, Patient, Growth, Therapy, Pharmaceutical industry, Contraceptive patch

PRINCETON, N.J., June 13, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq: AGRX), a women's healthcare company, today announced an agreement with vitaCare Prescription Services, a wholly owned subsidiary of GoodRx, to expand patient access and streamline fulfillment for Twirla (levonorgestrel ethinyl estradiol) transdermal system. VitaCare is a technology and services platform that helps patients navigate key access barriers for branded medications.

Key Points: 
  • VitaCare is a technology and services platform that helps patients navigate key access barriers for branded medications.
  • “The agreement with vitaCare aligns with our strategy to utilize partnerships to efficiently grow Twirla while continuing to responsibly manage our operating expenses,” said Agile Therapeutics’ Chief Commercial Officer Amy Welsh.
  • Twentyeight Health is a telehealth company providing affordable access and convenience for reproductive and sexual health and recently acquired the platform assets for SimpleHealth.
  • The Company believes that the Twentyeight Health platform will provide an opportunity for more patients to learn about and access Twirla.

AM Best Announces Winner of 2023 Student Challenge

Retrieved on: 
Thursday, June 1, 2023
Professional Services, Education, Other Professional Services, Insurance, Other Education, University, World Market (store), Database, Telehealth, AM Best, ALL, Florida State University, GoodRx, CVS, Risk management, Prescription, Information services, United States v. Students Challenging Regulatory Agency Procedures, Organization, Death, Student, AM, Optum, News, Health insurance, Management, Pharmaceutical industry, Walgreens

AM Best has announced that Hannah Youngblood from Florida State University is the winner of AM Best’s 2023 Student Challenge for her proposal to create a telemedicine platform for prescriptions that would address the issue of inadequate insurance coverage and high prescription costs.

Key Points: 
  • AM Best has announced that Hannah Youngblood from Florida State University is the winner of AM Best’s 2023 Student Challenge for her proposal to create a telemedicine platform for prescriptions that would address the issue of inadequate insurance coverage and high prescription costs.
  • AM Best’s 2023 Student Challenge is sponsored by the AM Best Foundation, which financially supports charitable organizations that encourage education and thought leadership in insurance and risk management.
  • To view interviews with Youngblood, as well as the other finalists, please visit AM Best's 2023 Student Challenge landing page.
  • AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry.

GoodRx to Present at the Jefferies Healthcare Conference

Retrieved on: 
Thursday, May 25, 2023
Medical Supplies, Health, Managed Care, General Health, Pharmaceutical, Biotechnology, GoodRx, Conference, The Interpublic Group of Companies, Cryptocurrency, Online shopping

GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading digital healthcare platform, today announced that executives from the Company will be presenting at the Jefferies Healthcare Conference in New York, NY on Thursday, June 8, 2023 at 12:30 p.m. Pacific Time (3:30 p.m. Eastern Time).

Key Points: 
  • GoodRx Holdings, Inc. (Nasdaq: GDRX), a leading digital healthcare platform, today announced that executives from the Company will be presenting at the Jefferies Healthcare Conference in New York, NY on Thursday, June 8, 2023 at 12:30 p.m. Pacific Time (3:30 p.m. Eastern Time).
  • A live webcast of the presentation will be available on the Company's Investor Relations website, https://investors.goodrx.com/ .
  • Following the conference, an archived recording will be available on the Company’s website for at least 30 days.

FTC Proposes Amendments to Strengthen and Modernize the Health Breach Notification Rule

Retrieved on: 
Thursday, May 18, 2023
Regulations.gov, Consumer protection, Accountability Act, Health Insurance Portability and Accountability Act, Register, Marketing, GoodRx, Commission, Policy, Federal, Blog, Privacy, Social media, Federal Trade Commission, Name, Acquisition, Federal Register, HIPAA, FTC, Comment, Fertility, Compliance, PHR, Health, News, Medical device, Dietary supplement, Property management
Key Points: 

FTC Proposes Amendments to Strengthen and Modernize the Health Breach Notification Rule

Retrieved on: 
Thursday, May 18, 2023
Regulations.gov, Consumer protection, Accountability Act, Health Insurance Portability and Accountability Act, Register, Marketing, GoodRx, Commission, Policy, Federal, Blog, Privacy, Social media, Federal Trade Commission, Name, Acquisition, Federal Register, HIPAA, FTC, Comment, Fertility, Compliance, PHR, Health, News, Medical device, Dietary supplement, Property management

The Federal Trade Commission is seeking comment on proposed changes to the Health Breach Notification Rule (HBNR) that include clarifying the rule’s applicability to health apps and other similar technologies.

Key Points: 
  • The Federal Trade Commission is seeking comment on proposed changes to the Health Breach Notification Rule (HBNR) that include clarifying the rule’s applicability to health apps and other similar technologies.
  • Since the rule’s issuance, health apps and other direct-to-consumer health technologies, such as fitness trackers, have become commonplace.
  • In September 2021, the FTC issued a policy statement affirming that health apps and connected devices that collect or use consumers’ health information must comply with the Health Breach Notification Rule.
  • After reviewing the public comments and consistent with the policy statement, the Commission has proposed the following changes to the HBNR:


The public will have 60 days after the notice is published in the Federal Register to submit comments on the proposed changes to the rule. Information on how to submit a comment can be found in the notice. Once processed, the comments will be posted to Regulations.gov. The Commission voted 3-0 at an open Commission meeting to publish the proposed changes to the HBNR in the Federal Register.

Ovulation Tracking App Premom Will be Barred from Sharing Health Data for Advertising Under Proposed FTC Order

Retrieved on: 
Wednesday, May 17, 2023
Consumer protection, Department, Advertising, Pregnancy, Wi-Fi, Justice, File, GoodRx, Commission, Health care, 2017–2018 Department of Justice metadata seizures, DOJ, Ovulation, Disclosure, AppsFlyer, Blog, Privacy, Social media, District, Federal Trade Commission, Complaint, District court, Qi Jiguang, Acquisition, FTC, Fertility, Seizure, Health (Apple), Android SDK, Virginia General District Court, Douglas v. U.S. District Court ex rel Talk America, News, SDK, Medical device, Birth control, Mobile phone, Facebook, Google
Key Points: 

Ovulation Tracking App Premom Will be Barred from Sharing Health Data for Advertising Under Proposed FTC Order

Retrieved on: 
Wednesday, May 17, 2023
Consumer protection, Department, Advertising, Pregnancy, Wi-Fi, Justice, File, GoodRx, Commission, Health care, 2017–2018 Department of Justice metadata seizures, DOJ, Ovulation, Disclosure, AppsFlyer, Blog, Privacy, Social media, District, Federal Trade Commission, Complaint, District court, Qi Jiguang, Acquisition, FTC, Fertility, Seizure, Health (Apple), Android SDK, Virginia General District Court, Douglas v. U.S. District Court ex rel Talk America, News, SDK, Medical device, Birth control, Mobile phone, Facebook, Google

“We will vigorously enforce the Health Breach Notification Rule to defend consumer's health data from exploitation.

Key Points: 
  • “We will vigorously enforce the Health Breach Notification Rule to defend consumer's health data from exploitation.
  • As part of a proposed order filed by the Department of Justice on behalf of the FTC, Illinois-based Easy Healthcare Corporation, which operates the Premom app, would be barred from sharing users’ personal health data with third parties for advertising, required to obtain users’ consent before sharing health data for any other purpose, and must tell consumers how their personal data will be used.
  • Premom failed to fully disclose its data sharing practices, and also violated direct promises to users, the FTC says.
  • An SDK tracks a user’s interactions with an app and other identifiable information and shares that data with third parties.
  • The FTC also says Premom integrated SDKs from other third parties into the Premom app including from app analytics provider Umeng and analytics provider Jiguang and shared sensitive user data.
  • The Commission voted 3-0 to refer the complaint and stipulated final order to the Department of Justice for filing.
  • The DOJ filed the complaint and stipulated order in the U.S. District Court for the Northern District of Illinois.

PM360 Announces Winners of The Ninth Annual ELITE 100 Awards

Retrieved on: 
Tuesday, May 16, 2023
Nexium, Data science, Marketing, GoodRx, EVP, Hospira, Associate, Cardinal Health, Patient, McCourt, HR, Disease, Eli Lilly and Company, Constipation, Attention, Snow, Diagnosis, Entrepreneurship, Growth, Digital marketing, Immunology, FAAN, Engagement, Organon, Caregiver, PR, Ironwood Pharmaceuticals, Exception, COVID-19, IBS-C, Health, ELITE, Boehringer Ingelheim, Abdominal pain, Sustainability, ImmunoGen, RN, Bloating, CO, Providers, Glaucoma, Lead, Mirati Therapeutics, Regulatory science, AstraZeneca, HCP, Gastroesophageal reflux disease, Veeva Systems, Novartis, Omeprazole, Management, Pharmaceutical industry, Beauty salon, Generic drug, Esomeprazole, GERD

NEW YORK, May 16, 2023 /PRNewswire/ -- PM360, the premier information resource for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device sectors, today announced the winners of its 9th Annual ELITE 100. The ELITE (Exceptional • Leaders • Innovators • Transformers • Entrepreneurs) represent the most influential people and teams in the healthcare and life sciences industries based on their career accomplishments. Out of more than 500 submissions, 100 winners are selected by the PM360 editorial staff across various categories that span every facet of the industry.

Key Points: 
  • NEW YORK, May 16, 2023 /PRNewswire/ -- PM360, the premier information resource for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device sectors, today announced the winners of its 9th Annual ELITE 100.
  • Out of more than 500 submissions, 100 winners are selected by the PM360 editorial staff across various categories that span every facet of the industry.
  • PM360 also selects one person as the "Uber ELITE," or the individual among the nominees who best personifies the criteria of a PM360 ELITE.
  • McCourt will serve as the keynote speaker at the annual ELITE 100 Awards Event to celebrate this year's winners.

GoodRx Reports First Quarter 2023 Results

Retrieved on: 
Wednesday, May 10, 2023
Technology, Managed Care, Health, General Health, Pharmaceutical, Health Technology, Apps, Applications, Software, Internet, Mobile, Wireless, Telemedicine, Virtual Medicine, Advertising, Interim, IPO, Share repurchase, Marketing, GoodRx, GAAP, Leg, Acquisition, Gold, Growth, PTR, Environment, Macs, Video game, Pharmaceutical industry, Reinsurance, Bookkeeping, Management, Cryptocurrency, Adjustment

GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), a leading digital healthcare platform, has released its financial results for the first quarter 2023.

Key Points: 
  • GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), a leading digital healthcare platform, has released its financial results for the first quarter 2023.
  • As of March 31, 2023, GoodRx had cash and cash equivalents of $761.1 million and total outstanding debt of $665.3 million.
  • During the first quarter of 2023, we repurchased $9.5 million of Class A common stock, representing approximately 1.6 million shares.
  • For the second quarter and full year 2023, management is anticipating the following:

A New Paradigm for Consumer Health Data Privacy in Washington State

Retrieved on: 
Wednesday, May 3, 2023
Accountability Act, Advertising, Health Insurance Portability and Accountability Act, Legislation, Family Educational Rights and Privacy Act, GoodRx, Privacy Act, Act, Washington State Legislature, Gramm–Leach–Bliley Act, Privacy, Record, IP, ID, Federal Trade Commission, The Act, Sale, Complaint, Organization, FERPA, GLBA, Supreme, Name, Future of Privacy Forum, Collection, WCPA, BetterHelp, Health, IDS, Policy, HIPAA, Mobile phone, Medical imaging, Agency
Key Points: